As of 2025-06-22, the EV/EBITDA ratio of Adaptive Biotechnologies Corp (ADPT) is -14.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ADPT's latest enterprise value is 1,659.84 mil USD. ADPT's TTM EBITDA according to its financial statements is -115.71 mil USD. Dividing these 2 quantities gives us the above ADPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 14.8x | 12.2x |
| Forward P/E multiples | 12.8x - 15.6x | 14.2x |
| Fair Price | (10.28) - (11.83) | (10.62) |
| Upside | -199.0% - -214.0% | -202.3% |
| Date | EV/EBITDA |
| 2025-06-06 | -13.96 |
| 2025-06-05 | -13.67 |
| 2025-06-04 | -13.82 |
| 2025-06-03 | -13.77 |
| 2025-06-02 | -13.25 |
| 2025-05-30 | -13.22 |
| 2025-05-29 | -12.94 |
| 2025-05-28 | -12.73 |
| 2025-05-27 | -12.72 |
| 2025-05-23 | -12.44 |
| 2025-05-22 | -12.32 |
| 2025-05-21 | -12.65 |
| 2025-05-20 | -13.01 |
| 2025-05-19 | -12.80 |
| 2025-05-16 | -12.60 |
| 2025-05-15 | -12.41 |
| 2025-05-14 | -12.59 |
| 2025-05-13 | -12.91 |
| 2025-05-12 | -13.20 |
| 2025-05-09 | -12.57 |
| 2025-05-08 | -12.89 |
| 2025-05-07 | -12.28 |
| 2025-05-06 | -12.28 |
| 2025-05-05 | -13.88 |
| 2025-05-02 | -13.64 |
| 2025-05-01 | -10.38 |
| 2025-04-30 | -10.38 |
| 2025-04-29 | -10.71 |
| 2025-04-28 | -10.92 |
| 2025-04-25 | -11.09 |
| 2025-04-24 | -11.08 |
| 2025-04-23 | -10.41 |
| 2025-04-22 | -9.92 |
| 2025-04-21 | -9.68 |
| 2025-04-17 | -10.34 |
| 2025-04-16 | -10.55 |
| 2025-04-15 | -10.88 |
| 2025-04-14 | -10.98 |
| 2025-04-11 | -11.14 |
| 2025-04-10 | -10.86 |
| 2025-04-09 | -11.72 |
| 2025-04-08 | -10.78 |
| 2025-04-07 | -10.83 |
| 2025-04-04 | -10.52 |
| 2025-04-03 | -10.45 |
| 2025-04-02 | -11.14 |
| 2025-04-01 | -10.59 |
| 2025-03-31 | -10.47 |
| 2025-03-28 | -10.79 |
| 2025-03-27 | -11.51 |